B. Stein

2.2k total citations · 1 hit paper
27 papers, 1.4k citations indexed

About

B. Stein is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Epidemiology. According to data from OpenAlex, B. Stein has authored 27 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 8 papers in Pulmonary and Respiratory Medicine and 4 papers in Epidemiology. Recurrent topics in B. Stein's work include CAR-T cell therapy research (5 papers), Bone health and treatments (4 papers) and Bone and Joint Diseases (4 papers). B. Stein is often cited by papers focused on CAR-T cell therapy research (5 papers), Bone health and treatments (4 papers) and Bone and Joint Diseases (4 papers). B. Stein collaborates with scholars based in Australia, United States and Belgium. B. Stein's co-authors include Alastair N. Goss, Andrew Cheng, Nicholas J. Petrelli, Harold O. Douglass, Neal J. Meropol, Deborah L. Driscoll, Giuseppina Arcangeli, A. Cheng, Bruce Allen Bach and Eric Winquist and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Immunology and Cancer.

In The Last Decade

B. Stein

24 papers receiving 1.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cisplatin and fluorouracil with or without panitumumab in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck (SPECTRUM): an open-label phase 3 randomised trial

2013 314 citations Jan B. Vermorken, Ірина Давиденко et al. The Lancet Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
B. Stein Australia	13	1.1k	524	263	208	161	27	1.4k
Joseph W. Leach United States	19	1.0k 1.0×	152 0.3×	393 1.5×	14 0.1×	42 0.3×	55	1.4k
Lydia Gedmintas United States	10	595 0.6×	180 0.3×	217 0.8×	4 0.0×	85 0.5×	16	894
Berksoy Şahin Türkiye	17	322 0.3×	71 0.1×	109 0.4×	11 0.1×	47 0.3×	59	840
Robert R. Carroll United States	10	705 0.7×	133 0.3×	184 0.7×	13 0.1×	9 0.1×	14	894
A. Heyll Germany	22	331 0.3×	69 0.1×	238 0.9×	14 0.1×	28 0.2×	65	1.7k
Ashwin Kashyap United States	11	530 0.5×	35 0.1×	98 0.4×	26 0.1×	41 0.3×	13	1.8k
Christine Elser Canada	16	473 0.5×	53 0.1×	231 0.9×	116 0.6×	5 0.0×	43	901
Hélder Antônio Rebelo Pontes Brazil	20	275 0.3×	12 0.0×	136 0.5×	70 0.3×	331 2.1×	122	1.1k
Glauco Baiocchi Brazil	23	461 0.4×	13 0.0×	262 1.0×	32 0.2×	59 0.4×	150	1.7k
Christoph Glanzmann Switzerland	26	1.0k 1.0×	12 0.0×	1.1k 4.1×	947 4.6×	35 0.2×	59	2.3k

Countries citing papers authored by B. Stein

Since Specialization

Citations

This map shows the geographic impact of B. Stein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B. Stein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B. Stein more than expected).

Fields of papers citing papers by B. Stein

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B. Stein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B. Stein. The network helps show where B. Stein may publish in the future.

Co-authorship network of co-authors of B. Stein

This figure shows the co-authorship network connecting the top 25 collaborators of B. Stein. A scholar is included among the top collaborators of B. Stein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B. Stein. B. Stein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

O’Neill, Niamh, David W. Johnson, Aisling Kelly, et al.. (2025). A methodology for determining dosing recommendations for anticancer drugs in patients with reduced kidney function. EClinicalMedicine. 82. 103101–103101.

Desai, Jayesh, Sophia Frentzas, Marwan Fakih, et al.. (2025). First-in-human, phase 1a, dose escalation study of BGB-B167, a CEA x 4-1BB bispecific antibody, as monotherapy or combined with tislelizumab (anti-PD-1), in patients with selected advanced or metastatic solid tumors.. Journal of Clinical Oncology. 43(4_suppl). 123–123.

Grob, Jean‐Jacques, Samantha Bowyer, Fiona Day, et al.. (2022). 818P Phase II confirmatory study of cemiplimab (350mg IV Q3W) in patients with locally advanced or metastatic cutaneous squamous cell carcinoma (CSCC): Study 1540 Group 6. Annals of Oncology. 33. S921–S921. 2 indexed citations

Wetter, Julie, Peter A. Kraus, Shawgi Sukumaran, et al.. (2021). Phase Ib, international, dose-escalation study to evaluate the safety, pharmacokinetics (PK) and efficacy of ST-617 for the attenuation of oral mucositis (OM) in patients receiving chemoradiation (CRT) for head and neck (H&N) cancer.. Journal of Clinical Oncology. 39(15_suppl). 6075–6075. 1 indexed citations

Wetter, Julie, Petra Kraus, Shawgi Sukumaran, et al.. (2020). 1846P Phase Ib, international, dose-escalation study to evaluate the safety, pharmacokinetics (PK) and efficacy of ST-617 a dithiolethione, for the attenuation of oral mucositis (OM) in patients receiving chemoradiation (CRT) for head & neck (H&N) cancer. Annals of Oncology. 31. S1058–S1059. 2 indexed citations

Crawford, Gregory B., et al.. (2020). Effects of a prescribed, supervised exercise programme on tumour disease progression in oncology patients undergoing anti‐cancer therapy: a retrospective observational cohort study. Internal Medicine Journal. 53(1). 104–111. 5 indexed citations

Cui, Wanyuan, Aisling Kelly, Craig Lewis, et al.. (2019). Dose modification for haematological toxicity: a survey of Australian medical oncologists. Internal Medicine Journal. 50(11). 1338–1343. 1 indexed citations

Guminski, Alexander & B. Stein. (2019). Immunotherapy and other systemic therapies for cutaneous SCC. Oral Oncology. 99. 104459–104459. 17 indexed citations

Karapetis, Christos S., B. Stein, Bogda Koczwara, et al.. (2018). Medical Oncology Group of Australia position statement and membership survey on voluntary assisted dying. Internal Medicine Journal. 48(7). 774–779. 23 indexed citations

10.

Cheng, Andrew, et al.. (2016). Postoperative Bleeding Following Dental Extractions in Patients Anticoagulated With Warfarin. Journal of Oral and Maxillofacial Surgery. 74(8). 1518–1523. 24 indexed citations

11.

Cheng, Andrew, et al.. (2014). A C-Terminal Crosslinking Telopeptide Test–Based Protocol for Patients on Oral Bisphosphonates Requiring Extraction: A Prospective Single-Center Controlled Study. Journal of Oral and Maxillofacial Surgery. 72(8). 1456–1462. 30 indexed citations

12.

Vermorken, Jan B., Ірина Давиденко, Lisa Licitra, et al.. (2013). Cisplatin and fluorouracil with or without panitumumab in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck (SPECTRUM): an open-label phase 3 randomised trial. The Lancet Oncology. 14(8). 697–710. 314 indexed citations breakdown →

13.

Boyer, Michael, Nick Pavlakis, Paul de Souza, et al.. (2012). Efficacy of erlotinib in patients with advanced Non‐small‐cell Lung Cancer (NSCLC): Analysis of the Australian subpopulation of the TRUST study. Asia-Pacific Journal of Clinical Oncology. 8(3). 248–254. 4 indexed citations

14.

Cools, Nathalie, B. Stein, Ann Van de Velde, et al.. (2010). Efficient mRNA electroporation of peripheral blood mononuclear cells to detect memory T cell responses for immunomonitoring purposes. Journal of Immunological Methods. 354(1-2). 1–10. 23 indexed citations

15.

Cheng, A., et al.. (2009). Alveolar bone and the bisphosphonates. Australian Dental Journal. 54(s1). S51–61. 32 indexed citations

16.

Cheng, Andrew, et al.. (2007). Nature and Frequency of Bisphosphonate-Associated Osteonecrosis of the Jaws in Australia. Journal of Oral and Maxillofacial Surgery. 65(3). 415–423. 489 indexed citations

17.

Monfardini, S., Matti Aapro, John M. Bennett, et al.. (2007). Organization of the clinical activity of Geriatric Oncology: Report of a SIOG (International Society of Geriatric Oncology) task force. Critical Reviews in Oncology/Hematology. 62(1). 62–73. 27 indexed citations

18.

Cheng, A., et al.. (2005). The dental implications of bisphosphonates and bone disease. Australian Dental Journal. 50(s2). S4–13. 104 indexed citations

19.

Khew‐Goodall, Yeesim, Carol Wadham, B. Stein, Jennifer R. Gamble, & Mathew A. Vadas. (1999). Stat6 Activation Is Essential for Interleukin-4 Induction of P-Selectin Transcription in Human Umbilical Vein Endothelial Cells. Arteriosclerosis Thrombosis and Vascular Biology. 19(6). 1421–1429. 48 indexed citations

20.

Stein, B., Nicholas J. Petrelli, Harold O. Douglass, et al.. (1995). Age and sex are independent predictors of 5-fluorouracil toxicity. Analysis of a large scale phase III trial. Cancer. 75(1). 11–17. 213 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact